Liquidia Corporation
LQDA
Kedudukan dalam Saham
#4685
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating... Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Harga Saham
$36.17
Modal Pasaran
$3.24B
Perubahan (1 hari)
5.98%
Perubahan (1 tahun)
48.00%
Negara
US
Perdagangan Liquidia Corporation (LQDA)
Kategori
Healthcare
Sejarah pecahan saham untuk Liquidia Corporation (LQDA)
Saham Liquidia Corporation (simbol: LQDA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham LQDA yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham LQDA.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham LQDA yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham LQDA.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
US
|
|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 0 | - |
US
|
